On this page

Elase-chloromycetin

fibrinolysin and desoxyribonuclease combined [bovine], with chloramphenicol

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Elase-chloromycetin

Proper name

fibrinolysin and desoxyribonuclease combined [bovine], with chloramphenicol

Licence type

351(a)

BLA number

050294

Applicant

Parke-Davis, a Division of Pfizer Inc.

Center

CDER

Presentations

First licensure

—

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
10MG/GM; 666UNITS/GM; 1UNIT/GM	Ointment	Topical	Tube	Disc	April 1, 1964

Purple Book	FDA	Licence type, presentations, reference product, exclusivity